Skip to content

Transvaginal Appendectomy

Transvaginal Appendectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00806429
Enrollment
20
Registered
2008-12-10
Start date
2008-08-31
Completion date
2011-12-31
Last updated
2017-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis

Keywords

appendicitis, surgery, laparoscopy, natural orifice transluminal surgery

Brief summary

The purpose of this study is to determine the feasibility and safety of transvaginal appendectomy and determine and compare the postoperative pain and quality of life after surgery to standard laparoscopic transabdominal appendectomy.

Interventions

patient undergoes transvaginal appendectomy

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ultrasound or CT-based diagnosis of acute or chronic appendicitis * ASA classification 1 or 2

Exclusion criteria

* BMI \>35 * on Immunosuppressive meds or immunocompromised * on blood thinners or aspirin or abnormal coagulation tests * h/o ectopic pregnancy, PID or endometriosis * prior open abdominal surgery or transvaginal surgery * with diffuse peritonitis * evidence of abscess * retroflexed uterus * non english speaking

Design outcomes

Primary

MeasureTime frame
feasibility of transvaginal appendectomy1 year

Secondary

MeasureTime frame
pain1 year
quality of life1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026